Moreover, a decrease of >50% regarding tumor markers like serum breast cancer antigen BR2729 (BR2729 or CA15-3) and/or carcinoembryonic antigen (CEA) was experienced in some patients. The gene discussed is CEACAM5; the disease is neoplasm.